Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-14
DOI
10.1002/med.21876
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells
- (2021) Mengmeng Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression
- (2021) Lijun Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma
- (2021) Lei Guo et al. LIFE SCIENCES
- Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
- (2021) Jing Liu et al. Nature Communications
- Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer
- (2021) Xiao Luo et al. Aging-US
- Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
- (2021) Ze-Bo Jiang et al. CANCER LETTERS
- The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer
- (2021) Lihua Liu et al. PHYTOMEDICINE
- Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based “combo” nanoagent together with PD-L1 blockade in reversing multidrug resistance
- (2021) Weixi Jiang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells
- (2021) Alexis Rugamba et al. Cells
- Resveratrol attenuates TNBC lung metastasis by down-regulating PD-1 expression on pulmonary T cells and converting macrophages to M1 phenotype in a murine tumor model
- (2021) Xu Han et al. CELLULAR IMMUNOLOGY
- Anticancer effects of asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro
- (2021) Zhu Zhu et al. PHYTOMEDICINE
- Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity
- (2020) Sara Verdura et al. Aging-US
- Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum
- (2020) Divyanshu Dubey et al. ANNALS OF NEUROLOGY
- CTLA-4 correlates with immune and clinical characteristics of glioma
- (2020) Fangkun Liu et al. Cancer Cell International
- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade
- (2020) Julie Vackova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- (Curcumin+sildenafil) enhances the efficacy of 5FU and anti‐PD1 therapies in vivo
- (2020) Paul Dent et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
- (2020) Thijs T. Wind et al. MELANOMA RESEARCH
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy
- (2020) Zecong Xiao et al. Science Advances
- Reverting Immune Suppression to Enhance Cancer Immunotherapy
- (2020) Bella S. Guerrouahen et al. Frontiers in Oncology
- Aptamer-T Cell Targeted Therapy for Tumor Treatment Using Sugar Metabolism and Click Chemistry
- (2020) Chuan-Gang Liu et al. ACS Chemical Biology
- β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT
- (2020) Yufei Liang et al. ACTA HISTOCHEMICA
- Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer
- (2020) Xuqian Deng et al. BIOCHEMICAL PHARMACOLOGY
- Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment
- (2020) Jinhui Liu et al. GENOMICS
- The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells
- (2020) Dong Young Kang et al. Cancers
- Comprehensive analysis of CTLA-4 in the tumor immune microenvironment of 33 cancer types
- (2020) Chufan Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer
- (2020) Yang Shen et al. Journal for ImmunoTherapy of Cancer
- Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
- (2020) Yang Liu et al. Acta Pharmaceutica Sinica B
- Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
- (2020) Leïla Sarah Sellam et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors
- (2020) Xinying Tang et al. CANCER LETTERS
- Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3
- (2020) Taeko Hayakawa et al. CANCER SCIENCE
- Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients
- (2020) Chin-Shan Kuo et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
- (2020) Elisabeth Pérez-Ruiz et al. DRUG RESISTANCE UPDATES
- The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study
- (2020) Maria D’Souza et al. EUROPEAN HEART JOURNAL
- Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
- (2019) Sema Kurtulus et al. IMMUNITY
- Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
- (2019) Imran Siddiqui et al. IMMUNITY
- Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
- (2019) Xiaoyun Li et al. Nature Reviews Clinical Oncology
- Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
- (2019) Xin Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
- (2019) Sandra Tuyaerts et al. BMC CANCER
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- Conformation space of a heterodimeric ABC exporter under turnover conditions
- (2019) Susanne Hofmann et al. NATURE
- Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
- (2019) Audrey Simonaggio et al. JAMA Oncology
- Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
- (2019) Tawnie J Braaten et al. ANNALS OF THE RHEUMATIC DISEASES
- γ-secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
- (2019) Margot J. Pont et al. BLOOD
- IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
- (2019) Alexander Thiem et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
- (2019) Guoping Ding et al. BMC CANCER
- Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production
- (2019) Kei Watari et al. BMC Veterinary Research
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- Anthocyanins, delphinidin-3-O-glucoside and cyanidin-3-O-glucoside, inhibit immune checkpoints in human colorectal cancer cells in vitro and in silico
- (2019) Candice Mazewski et al. Scientific Reports
- Ginsenoside Rh2 improves the cisplatin anti-tumor effect in lung adenocarcinoma A549 cells via superoxide and PD-L1
- (2019) Yingying Chen et al. Anti-Cancer Agents in Medicinal Chemistry
- PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
- (2019) Yunlong Zhao et al. IMMUNITY
- Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis
- (2019) Junjie Yin et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma
- (2018) Feng Liao et al. ARCHIVES OF ORAL BIOLOGY
- Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
- (2018) Giuseppe Badalamenti et al. CELLULAR IMMUNOLOGY
- Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
- (2018) Yinghao Zhao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts
- (2018) Ping-Pin Zheng et al. DRUG DISCOVERY TODAY
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury
- (2018) Yoh Zen et al. MODERN PATHOLOGY
- Multiclonal tumor origin: Evidence and implications
- (2018) Barbara L. Parsons MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- (2018) Ferdinandos Skoulidis et al. Cancer Discovery
- Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
- (2018) Mélanie Saint-Jean et al. Journal of Immunology Research
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reaction
- (2018) Zhongmin Tang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-ligand 1 Signaling Pathway
- (2018) Tianyu Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
- (2018) Anchalee Rawangkan et al. MOLECULES
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells
- (2018) Sangmin Kim et al. PHYTOMEDICINE
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
- (2018) Hyung-Don Kim et al. GASTROENTEROLOGY
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
- (2018) Lu Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
- (2018) Shunsuke Kitajima et al. Cancer Discovery
- Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
- (2017) Xun Wang et al. IMMUNOLOGY LETTERS
- Identifying specificity groups in the T cell receptor repertoire
- (2017) Jacob Glanville et al. NATURE
- The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans
- (2017) J. Luis Espinoza et al. Oxidative Medicine and Cellular Longevity
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
- (2017) Krzysztof M. Zak et al. STRUCTURE
- PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
- (2017) Shengwei Liu et al. Oncotarget
- Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells
- (2017) Soumaye Amirsaadat et al. Artificial Cells Nanomedicine and Biotechnology
- Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer
- (2017) Mei Zhang et al. OncoImmunology
- Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer
- (2017) Nadine Nelson et al. PLoS One
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
- (2016) Melanie R. Power Coombs et al. CANCER LETTERS
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Triptolide induced cell death through apoptosis and autophagy in murine leukemia WEHI-3 cellsin vitroand promoting immune responses in WEHI-3 generated leukemia micein vivo
- (2016) Shih-Feng Chan et al. ENVIRONMENTAL TOXICOLOGY
- Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
- (2016) Nghia Nguyen et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer
- (2016) Dan Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The enhancement of immune function and activation of NF-κB by resveratrol-treatment in immunosuppressive mice
- (2016) Xin Lai et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses
- (2016) Yongling Ning et al. INTERNATIONAL JOURNAL OF CANCER
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
- (2016) Frank B. Cortazar et al. KIDNEY INTERNATIONAL
- Berberine and inflammatory bowel disease: A concise review
- (2016) Solomon Habtemariam PHARMACOLOGICAL RESEARCH
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Ginsenoside Rh2 enhances the antitumor immunological response of a melanoma mice model
- (2016) Meng Wang et al. Oncology Letters
- Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
- (2016) Lewis Zhichang Shi et al. Nature Communications
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model
- (2015) Liang Chen et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
- (2015) Marta Garnelo et al. GUT
- Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype
- (2015) Min Liu et al. JOURNAL OF IMMUNOLOGY
- Erratum: Corrigendum: Linking T-cell receptor sequence to functional phenotype at the single-cell level
- (2015) Arnold Han et al. NATURE BIOTECHNOLOGY
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models
- (2015) Myriam Lamrani et al. OncoImmunology
- Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity
- (2013) Alan G. Ramsay BRITISH JOURNAL OF HAEMATOLOGY
- Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
- (2013) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells
- (2013) C. Lee-Chang et al. JOURNAL OF IMMUNOLOGY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Triptolide Downregulates Treg Cells and the Level of IL-10, TGF-β, and VEGF in Melanoma-Bearing Mice
- (2013) Biao Liu et al. PLANTA MEDICA
- In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells
- (2012) Dhanya Nambiar et al. CANCER LETTERS
- PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN- Inducible Chemokines
- (2012) W. Peng et al. CANCER RESEARCH
- Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
- (2012) Esdy N. Rozali et al. Clinical & Developmental Immunology
- Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro
- (2012) Guang-ju Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Antioxidant, Antiproliferative, and Pro-Apoptotic Activities of a Saponin Extract Derived from the Roots of Panax notoginseng (Burk.) F.H. Chen
- (2012) Nian-Wu He et al. JOURNAL OF MEDICINAL FOOD
- Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma
- (2012) Hongbing Guan et al. PLoS One
- Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN- +IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors
- (2011) N. A. Marshall et al. CANCER RESEARCH
- Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
- (2011) P. B. Olkhanud et al. CANCER RESEARCH
- The emerging role of viruses in the treatment of solid tumours
- (2011) M.G. Bourke et al. CANCER TREATMENT REVIEWS
- Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity
- (2011) Feifei Luo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts
- (2010) Sankar Bhattacharyya et al. Cellular & Molecular Immunology
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases
- (2010) Suk-Bin Seo et al. Molecular Cancer
- Apigenin: A Promising Molecule for Cancer Prevention
- (2010) Sanjeev Shukla et al. PHARMACEUTICAL RESEARCH
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- The effects of β-glucan on human immune and cancer cells
- (2009) Godfrey Chan et al. Journal of Hematology & Oncology
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Anti-CTLA-4 therapy results in higher CD4+ICOShiT cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
- (2009) Hong Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triptolide inhibits interferon-γ-induced programmed death-1-ligand 1 surface expression in breast cancer cells
- (2008) Mei Liang et al. CANCER LETTERS
- Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells
- (2008) Yoolhee Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma
- (2008) Eishiro Mizukoshi et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now